Figure 1From: Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score resultsOverall impact of knowing the Recurrence Score result on treatments received (n = 111).CHT chemohormonal therapy; HT hormonal therapy.Back to article page